. 2020 Oct 21;3:593. doi: 10.1038/s42003-020-01304-6

Table 1.

Distribution of cancer spectrum in Cep55 transgenic mice.

No.	Cancerous Lesions	Cep55^wt/wt(n = 40)		Cep55^wt/Tg(n = 40)		Cep55^Tg/Tg(n = 50)		Cep55^wt/wt vs Cep55^Tg/Tg, Cep55^wt/Tg vs Cep55^Tg/Tg
		#	%	#	%	#	%	p values^a
1	Lymphoma	0	0	0	0	18	51.42	6.0 × 10⁻⁶	6.0 × 10⁻⁶
	B-Cell Lymphoma	–		–		11	61.11	0.0010	0.0010
	T-Cell Lymphoma	–		–		7	38.88	0.0159	0.0159
2	Undifferentiated sarcoma	0	0	0	0	9	25.71	0.0039	0.0039
	Fibrosarcoma	–		–		3	33.33	0.2509	0.2509
	Hemangiosarcoma	–		–		6	66.67	0.0317	0.0317
3	Bronchogenic adenocarcinoma	0	0	0	0	6	17.14	0.0317	0.0317
4	Hepatocellular Carcinoma	0	0	0	0	3	8.57	0.2509	0.2509
5	Gastric Carcinoma	0	0	0	0	5	14.28	0.0632	0.0632
6	Intestinal Papillary Carcinoma	0	0	0	0	3	8.57	0.2509	0.2509
7	Myelogenous Leukemia	0	0	0	0	7	20	0.0159	0.0159
8	Hepatic Hyperplasia (foci of cellular alteration)	1	2.22	4	8.69	12	34.28	0.0051	0.1019
9	Splenic follicular Hyperplasia	1	2.22	4	8.69	8	66.66	0.0398	0.5373
10	Endometrial Hyperplasia	0	0	0	0	4	33.33	0.1259	0.1259
11	Lipoma	0	0	0	0	1	2.9	1.0	1.0
12	Alveolar-Bronchiolar Adenoma	0	0	10	22.22	15	42.85	0.0001	0.6426
13	Hepatoma	0	0	2	4.34	2	5.7	0.5006	1.0

^aP values: Fisher’s exact tests.